国泰创新医疗混合发起C(018160)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2025-03-30 |
6,103,912.95 |
7,451,177.63 |
9,150,304.31 |
7,803,039.63 |
| 2024-12-30 |
6,279,398.11 |
6,103,912.95 |
2,710,929.87 |
2,886,415.03 |
| 2024-09-29 |
7,469,176.51 |
6,279,398.11 |
2,800,037.68 |
3,989,816.08 |
| 2024-06-29 |
7,760,054.97 |
7,469,176.51 |
3,007,007.56 |
3,297,886.02 |
| 2024-03-30 |
11,886,496.87 |
7,760,054.97 |
4,067,085.43 |
8,193,527.33 |
| 2023-12-30 |
1,653,409.51 |
11,886,496.87 |
28,094,534.22 |
17,861,446.86 |
| 2023-09-29 |
561,354.17 |
1,653,409.51 |
1,529,801.36 |
437,746.02 |
| 2023-06-29 |
561,354.17 |
561,354.17 |
- |
- |
欢迎访问证券之星！请点此与我们联系 版权所有： Copyright © 1996-年
微信公众号
证券之星APP
基本资料
